COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Endometrial Ablation Market would witness market growth of 6.3% CAGR during the forecast period (2018 – 2024).
Endometrial ablation is used in facilitating the destruction of endometrium or thin layer of the uterine wall, and is used in treating abnormal heavy uterine bleeding. Prolonged abnormal uterine bleeding could lead to low blood count and anemia. Endometrial ablation is a technique that has gained prominence as there is no need for incisions, and the technique is very popular among women suffering menstrual problems.

The application of endometrial ablation is on the rise, as it is a popular medical procedure used in the removal of the endometrial lining of a uterus to minimize abnormal uterine bleeding. Additionally, the market growth is further supported by the rising healthcare expenditure and increasing awareness among people.

Based on the Technology, the Endometrial Ablation market is segmented into Radiofrequency Ablation, Cryoablation, Hydrothermal Ablation, Thermal Balloon, Hysteroscopic Ablation, and Others. Based on the end user, the market is segmented into Hospitals, Clinics, and Ambulatory Surgical Centers. Based on countries, the Endometrial Ablation market segments the market into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the Europe Endometrial Ablation Market. Key companies profiled in the report include Smith & Nephew Plc, Olympus Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Ethicon, LLC. (Johnson & Johnson), Medtronic Plc, Hologic Corporation, Minerva Surgical, Inc., The Cooper Companies, Inc. (Cooper Surgical Inc.), and AngioDynamics Inc.